Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amar Deep Sharma

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Microbiology Spectrum|December 15, 2022
Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureusAmar Deep Sharma, William G Gutheil
International Journal of Molecular Sciences|January 30, 2021
Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer CellsVrinda Gote, Amar Deep Sharma, Dhananjay Pal
Cells|July 29, 2020
MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver InjuryJovana Markovic, Amar Deep Sharma, Asha Balakrishnan
Stem Cells (Dayton, Ohio)|December 20, 2014
Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developmentsTobias Cantz, Amar Deep Sharma, Michael Ott
Journal of Hepatology|May 11, 2020
Equal opportunity offer for all hepatocytesZhen Dai, Michael Ott, Amar Deep Sharma
Journal of Hepatology|October 17, 2017
About cytokeratin 19 and the drivers of liver regenerationNorman Junge, Amar Deep Sharma, Michael Ott
Journal of the American Society for Mass Spectrometry|November 14, 2018
LC-MS/MS-Based Separation and Quantification of Marfey's Reagent Derivatized Proteinogenic Amino Acid DL-StereoisomersNavid J Ayon, Amar Deep Sharma, William G Gutheil
Cell Stem Cell|May 5, 2023
Bioartificial liver with reprogrammed hepatocytes ready for prime timeRuomeng Li, Asha Balakrishnan, Michael Ott, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 12, 2024
"The Good, the Bad, and the Ugly" - About Diverse Phenotypes of Hepatic Stellate Cells in the LiverAlexandra Bogomolova, Asha Balakrishnan, Michael Ott, et al.
Journal of Hepatology|October 13, 2024
MicroRNA-107 - a small RNA with a big impact on cytokinesis in hepatocellular carcinomaXiaowei Zhong, Michael Ott, Amar Deep Sharma, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Microbiology Spectrum|December 15, 2022
Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureusAmar Deep Sharma, William G Gutheil
International Journal of Molecular Sciences|January 30, 2021
Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer CellsVrinda Gote, Amar Deep Sharma, Dhananjay Pal
Cells|July 29, 2020
MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver InjuryJovana Markovic, Amar Deep Sharma, Asha Balakrishnan
Stem Cells (Dayton, Ohio)|December 20, 2014
Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developmentsTobias Cantz, Amar Deep Sharma, Michael Ott
Journal of Hepatology|May 11, 2020
Equal opportunity offer for all hepatocytesZhen Dai, Michael Ott, Amar Deep Sharma
Journal of Hepatology|October 17, 2017
About cytokeratin 19 and the drivers of liver regenerationNorman Junge, Amar Deep Sharma, Michael Ott
Journal of the American Society for Mass Spectrometry|November 14, 2018
LC-MS/MS-Based Separation and Quantification of Marfey's Reagent Derivatized Proteinogenic Amino Acid DL-StereoisomersNavid J Ayon, Amar Deep Sharma, William G Gutheil
Cell Stem Cell|May 5, 2023
Bioartificial liver with reprogrammed hepatocytes ready for prime timeRuomeng Li, Asha Balakrishnan, Michael Ott, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 12, 2024
"The Good, the Bad, and the Ugly" - About Diverse Phenotypes of Hepatic Stellate Cells in the LiverAlexandra Bogomolova, Asha Balakrishnan, Michael Ott, et al.
Journal of Hepatology|October 13, 2024
MicroRNA-107 - a small RNA with a big impact on cytokinesis in hepatocellular carcinomaXiaowei Zhong, Michael Ott, Amar Deep Sharma, et al.
Pageof 6